Evaluating Hospital Data Warehouses for Cancer Real-World Evidence
Researchers in South Korea assessed hospital clinical data warehouses for generating real-world oncology evidence, finding high overall data availability but notable gaps in tracking specific clinical outcomes.
Key points
- Assessed 159 variables across two tertiary hospitals in South Korea using a gastric cancer use case.
- Found that 79.9 percent of variables were directly captured, while outcome endpoints showed limited feasibility.
- Emphasizes the need for targeted data validation before using hospital warehouses for oncology studies.
A recent feasibility assessment published in Nature Health Sciences has evaluated how effectively routinely collected hospital data can be used to generate real-world evidence in oncology. Researchers from institutions in South Korea, including Yonsei University and Asan Medical Center, used a gastric cancer post-listing study as a practical use case to examine clinical data warehouses across two tertiary hospitals. The team analyzed 159 prespecified variables using a PICOTS-informed framework to determine data availability, completeness, and formats.
The evaluation revealed that while 127 variables were directly captured and several others could be derived or ascertained, about 5.7 percent remained completely unavailable. The study found that while population eligibility, timing, and settings were generally feasible, tracking specific clinical outcomes proved challenging, particularly for interpretive endpoints that require complex clinical ascertainment. The authors noted that broad availability of information does not always translate into direct analytic readiness, underscoring the necessity of targeted validation and study-specific assessments.
What to know: Routine hospital databases hold immense potential for cancer research, but researchers must account for variable completeness and outcome tracking limitations before drawing firm conclusions.
Readers should consult a qualified healthcare professional regarding any personal medical decisions or treatment pathways.
Source Nature Health Sciences — nature.com/articles/s41598-026-78523-0 ↗
Read next
🏥Public HealthPreventive Services Task Force Resumes Meetings Under New Leadership
The U.S. Preventive Services Task Force is set to reconvene this week for the first time in over a year following a significant membership overhaul by Health Secretary Ro…
❤️Conditions & CareBlood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma
Researchers have identified a specific RNA signature in blood plasma that may help predict how well lymphoma patients respond to CAR T-cell therapy.
🧠Mind & Mental HealthAddressing Body Image and the Reality of Gluteal Anatomy
A personal reflection on the social and psychological impact of body shape, specifically regarding the gluteal region, and the limitations of consumer solutions for perce…
❤️Conditions & CareMigraine and Smoking Linked to Increased Early Stroke Risk in Women
A large-scale study suggests that people who have given birth and experience migraines while also smoking face a significantly higher risk of stroke before age 60.
🔬ResearchCBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities
A double-blind clinical trial published in JAMA Pediatrics indicates that CBD oil provides no significant behavioral improvement for children and teenagers with intellect…
🏃FitnessExpert Advice on Hydration Gear Sparks Debate Among Recreational Runners
Olympic medalist Josh Kerr recently suggested that runners may not require hydration packs for distances under 12 miles, igniting a broader conversation about gear necess…